Sign In
Buy IHE
$90.02
+1.03 (+1.16%)
At Close: Jun 03, 2026
ETFs to Buy as Eli Lilly Beats Q1 Earnings, Lifts Outlook
12:01pm, Wednesday, 01'st May 2024
Eli Lilly and Company (LLY) raised its outlook for 2024 on rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro.
JNJ Beats Q1 Earnings Estimates, Misses on Sales: ETFs in Focus
11:00am, Wednesday, 17'th Apr 2024
Johnson & Johnson (JNJ) continued with its long streak of earnings beat but lagged revenue estimates.
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
07:20am, Monday, 15'th Apr 2024
The iShares U.S. Pharmaceuticals ETF (IHE) was launched on 05/01/2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Pharma segment of the equity
This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?
09:27am, Wednesday, 10'th Apr 2024
A new exchange-traded fund needs an edge to attract investors. This might be its industry focus — a tall order in a crowded market with ETFs covering just about any industry you can imagine.
Time to Tap Healthcare ETFs on Nvidia's AI Ambition?
08:01am, Thursday, 04'th Apr 2024
At Nvidia's last week's GTC AI conference, the company announced partnerships in the healthcare sector, representing a strategic move toward expanding its revenue streams beyond tech sectors.
Looking for Bargain Hunting? Top-Ranked ETFs to Buy
02:01pm, Friday, 23'rd Feb 2024
Bargain hunting in a market where the S&P 500 is at record levels may seem like a daunting task, but it's not impossible.
5 ETFs at All-Time Highs as S&P 500 Rally Continues
09:46am, Friday, 16'th Feb 2024
The S&P 500 hit an all-time high on Thursday despite despite a weaker-than-expected retail sales report.
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
07:21am, Tuesday, 13'th Feb 2024
Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the iShares U.S. Pharmaceuticals ETF (IHE) is a passively managed exchange traded fund launched on 05/01/200
A Look at Pharma ETFs After Q4 Earnings
02:01pm, Monday, 12'th Feb 2024
The fourth-quarter results of the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 17.7% despite 7% revenue growth. However, many industry bigwigs re
ETFs to Buy as Mounjaro Powers Eli Lilly's Q4 Earnings Beat
11:06am, Wednesday, 07'th Feb 2024
Eli Lilly and Company (LLY) posted robust fourth-quarter 2023 earnings, beating estimates on both the top and bottom lines driven by strong sales of its diabetes and weight-loss treatments.
Pharma ETF (IHE) Hit a 52-Week High
01:40am, Wednesday, 07'th Feb 2024
Investors seeking momentum may have iShares U.S. Pharmaceuticals ETF IHE on radar now. The fund recently hit a new 52-week high.
Tech Leads S&P 500 to Highs: Does Further Rally Await ETFs?
01:01pm, Friday, 26'th Jan 2024
The S&P 500 has been hovering around an all-time high. The chart indicates that, on average, investments made at record highs tend to perform better over the next five years, as quoted on Yahoo Financ
Has the January Effect Finally Taken Off? ETFs in Focus
09:01am, Tuesday, 09'th Jan 2024
The January effect, while a famous market anomaly, is not as straightforward as it may seem. While Wall Street has been muted at the start of this year, it now seems that the anomaly has started to ta
3 Beaten-Down ETFs to Buy for a Turnaround in 2024
02:17pm, Friday, 22'nd Dec 2023
In the past three months, the S&P 500 has gained about 9.6%. We highlight a few ETFs that lost in the past three months but can rebound in 2024.
5 Secret Santa ETFs That Might Surprise You This Christmas
11:17am, Friday, 15'th Dec 2023
With Wall Street scaling new highs, there are some hidden gems, or Secret Santa as we call them, which could surprise investors with big returns this Christmas.
